ZEESHAN GULAM HUSSAIN

Allopathic & Osteopathic Physicians|Hospitalist WORCESTER, MA NPI 1164075768

General Payments — all program years on this page

$2,341.06

  • Category: General Payments
  • Program years: PY2019–2024
  • Record count: 103
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $490.73 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $490.7321

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2019 $58.313
2020 $135.327
2021 $321.0716
2022 $691.2429
2023 $644.3927
2024 $490.7321

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078041588 Janssen Pharmaceuticals, Inc $20.69 06/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078041884 Janssen Pharmaceuticals, Inc $17.11 08/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078891907 Actelion Pharmaceuticals US, Inc. $27.17 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078891939 Actelion Pharmaceuticals US, Inc. $37.45 10/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1081728457 Lexicon Pharmaceuticals, Inc. $20.48 08/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1081728459 Lexicon Pharmaceuticals, Inc. $22.78 06/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1081728461 Lexicon Pharmaceuticals, Inc. $29.78 06/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1081728463 Lexicon Pharmaceuticals, Inc. $33.35 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097082150 Novo Nordisk Inc $22.64 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097641778 Novo Nordisk Inc $20.45 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103958958 ABBVIE INC. $28.53 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104507094 AstraZeneca Pharmaceuticals LP $27.35 05/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104509260 AstraZeneca Pharmaceuticals LP $26.52 11/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105590362 AstraZeneca Pharmaceuticals LP $16.84 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120631764 Baxter Healthcare $21.35 05/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131230931 PFIZER INC. $24.13 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131244160 PFIZER INC. $18.95 03/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131494334 PFIZER INC. $14.77 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131621945 PFIZER INC. $14.00 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131621949 PFIZER INC. $15.67 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142279677 ABIOMED $30.72 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.